Equity Components [Axis]
Common Stock [Member]
Treasury Stock, Common [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Investment, Name [Axis]
Beyond Cancer Ltd [Member]
NeuroNos Ltd [Member]
Legal Entity [Axis]
Streeterville Capital LLC [Member]
Geographical [Axis]
UNITED STATES
AUSTRALIA
BERMUDA
IRELAND
CYPRUS
Income Tax Authority, Name [Axis]
Australian Taxation Office [Member]
Concentration Risk Benchmark [Axis]
Accounts Payable [Member]
Concentration Risk Type [Axis]
Customer Concentration Risk [Member]
Customer [Axis]
First Third Party Vendors [Member]
Second Third Party Vendors [Member]
Third Party Vendors [Member]
Revenue Benchmark [Member]
Customers One [Member]
Customers Two [Member]
Ownership [Axis]
Financial Instrument [Axis]
Mutual Funds [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Warrant [Member]
Mutual Fund [Member]
Extinguishment of Debt [Axis]
Short-Term Debt [Member]
Measurement Input Type [Axis]
Measurement Input, Expected Term [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Share Price [Member]
Measurement Input, Option Volatility [Member]
Derivative [Member]
Long-Lived Asset, Class [Axis]
Computer Equipment [Member]
Furniture and Fixtures [Member]
Clinical and Medical Equipment [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Equipment Deployable as Part of Service Offering [Member]
Leasehold Improvements [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
2025 ATM [Member]
Purchase Agreement [Member]
2026 Pre-funded Warrants [Member]
2026 Common Warrants [Member]
Pre-funded Warrants [Member]
Sale of Stock [Axis]
Private Placement [Member]
Plan Name [Axis]
2013 Beyond Air Equity Incentive Plan [Member]
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
2013 BA Plan [Member]
2013 BA EquityIncentivePlan [Member]
Share-Based Payment Arrangement, Option [Member]
2025 Option Repricing [Member]
2021 Beyond Cancer Ltd Equity Incentive Plan [Member]
2023 Neuro Nos Ltd Equity Incentive Plan [Member]
Amended Loan Agreement [Member]
2021 Employee Stock Purchase Plan [Member]
Restricted Stock [Member]
Beyond Air Inc. [Member]
Location, Statement of Income, Balance [Axis]
NitricGen Agreement [Member]
Avenue Agreement [Member]
March 2024 Raise [Member]
Avenue Extension Agreement [Member]
September 2024 equity offering [Member]
September 2024 Debt Instrument [Member]
September 2025 Inducement [Member]
January, 2026 Equity Offering [Member]
Sub Total [Member]
Pre Funded Warrants Sep 2024 [Member]
Pre Funded Warrants jan 2026 [Member]
Title and Position [Axis]
Steve Lisi [Member]
Antidilutive Securities [Axis]
Equity Option [Member]
Loan Agreement [Member]
Debt Instrument [Axis]
Promissory Note [Member]
Loan and Security Agreement [Member]
Director [Member]
Note Purchase Agreement [Member]
Income Tax Jurisdiction [Axis]
Income Tax Jurisdiction, Domestic Federal [Member]
Israel Tax Authority [Member]
Revenue Commissioners, Ireland [Member]
Cypriot Tax [Member]
Award Date [Axis]
No Expiration [Member]
Income Tax Jurisdiction, Domestic State and Local [Member]
Tax Credit Carryforward [Axis]
Research Tax Credit Carryforward [Member]
ISRAEL
Option Agreement [Member]
NitricGen, Inc [Member]
Next Milestones [Member]
After Six Months [Member]
Cost of Goods and Service Benchmark [Member]
Supplier Concentration Risk [Member]
Supplier [Member]
Certain Investors [Member]
Investors [Member]
Related and Nonrelated Parties [Axis]
Related Party [Member]
Subscription Agreement [Member]
Variable Interest Entities [Member]
Beyond Air [Member]
Segments [Axis]
Business Segment [Member]
Consolidated Entities [Axis]
Parent Company [Member]
Lung Fit PH [Member]
LungFit® PH [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Listing, Par Value Per Share
Auditor Firm ID
Auditor Opinion [Text Block]
Auditor Name
Auditor Location
Statement of Financial Position [Abstract]
ASSETS
Current assets
Cash and cash equivalents
Marketable securities
Restricted cash
Accounts receivable, net
Inventory, net
Other current assets and prepaid expenses
Total current assets
Licensed right to use technology
Right-of-use lease assets
Property and equipment, net
Other assets
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable
Accrued expenses and other current liabilities
Operating lease liabilities, current portion
Loans payable, current portion
Total current liabilities
Operating lease liabilities, net
Long-term debt, net
Warrant liability
Total liabilities
Commitments and contingencies (Note 12)
Stockholders’ equity
Preferred Stock, $0.0001 par value per share: 10,000,000 shares authorized, 0 shares issued and outstanding
Common Stock, $0.0001 par value per share: 500,000,000 shares authorized, 11,792,684 and 4,128,539 shares issued and outstanding as of March 31, 2026 and 2025, respectively
Treasury stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income/(loss)
Total stockholders’ equity attributable to Beyond Air, Inc.
Non-controlling interest
Total stockholders’ equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Revenues
Cost of revenues
Gross profit (loss)
Operating expenses:
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Other income/(expense):
Dividend/investment income
Interest and finance expense
Change in fair value of warrant liability
Change in fair value of derivative liability
Foreign exchange loss
Loss on extinguishment of debt
Loss on disposal/impairment of fixed assets
Other income/(expense)
Total other income/(expense)
Loss before income taxes
Provision for income taxes
Net loss
Less: net loss attributable to non-controlling interest
Net loss attributable to Beyond Air, Inc.
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustment
Comprehensive loss attributable to Beyond Air, Inc.
Net basic loss per share attributable to Beyond Air, Inc.
Net diluted loss per share attributable to Beyond Air, Inc.
Weighted average number of shares of common stock outstanding - basic
Weighted average number of shares of common stock outstanding - diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Issuance of common stock – At The Market equity offering
Issuance of common stock - At The Market equity offering, shares
Sale of common stock and pre-funded warrants
Sale of common stock and pre-funded warrants, shares
Issue of common stock warrants
Issuance of common stock upon exercise of warrants
Issuance of common stock upon exercise of warrants, shares
Issuance of common stock upon vesting of restricted shares
Issuance of common stock upon vesting of restricted shares, shares
NeuroNos issuance of stock
Stock-based compensation
Other comprehensive gain
Net loss
Issuance of common stock – 2025 Reverse Stock Split rounding
Issuance of common stock - 2025 Reverse Stock Split rounding, shares
Issuance of common stock for conversion of debt
Issuance of common stock for conversion of debt, shares
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Stock-based compensation
Amortization of debt discount and accretion of debt issuance costs
Amortization of licensed right to use technology
Amortization of operating lease assets
Change in fair value of warrant liability
Change in fair value of derivative liability
Unrealized loss on marketable securities
Provision for inventory losses
Provision for bad debt
Foreign currency adjustments
Loss on extinguishment of debt
Impairment of fixed assets
Loss on disposal of fixed assets
Paid in kind interest
Changes in:
Inventory
Accounts receivable
Other current assets and prepaid expenses
Accounts payable
Accrued expenses
Operating lease liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of marketable securities
Proceeds from sale of marketable securities
Security deposits made on operating leases
Purchase of property and equipment
Net cash (used in)/provided by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock through at the market offerings, net
Proceeds from the sale of common stock of NeuroNos
Proceeds from issuance of common stock and pre-funded warrants through securities purchase, net
Proceeds from issuance of common stock through exercise of warrants
Proceeds from issuance of common stock warrants
Proceeds from long term loan
Debt issuance costs
Payment of loan
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Increase/(decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental disclosure of non-cash investing and financing activities:
Debt discount
Derivative liability
Short term finance liability
Fixed assets recorded in accounts payable and accrued expenses
Right-of-use assets acquired under operating leases
Debt principal balance converted to equity
Interest paid
Income taxes paid
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
No insider trading flag
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BUSINESS
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES
Property, Plant, and Equipment [Abstract]
PROPERTY AND EQUIPMENT
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER CURRENT ASSETS AND PREPAID EXPENSES
Payables and Accruals [Abstract]
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Leases
LEASES
Earnings Per Share [Abstract]
BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK
Debt Disclosure [Abstract]
LOANS
LOAN PAYABLE
Income Tax Disclosure [Abstract]
INCOME TAXES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Segment Reporting [Abstract]
SEGMENTS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Lease Revenues
LEASE REVENUES
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Basis of Presentation and Principles of Consolidation
Use of Estimates
Going Concern, Liquidity and Other Uncertainties
Other Risks and Uncertainties
Revenue Recognition
Accounts Receivable
Fair Value Measurements
Warrant Liability
Derivative Liability
Cash and Cash Equivalents, Short-Term Investments and Restricted Cash
Concentration of Credit Risk
Fixed Assets
Segment Reporting
Inventories
Leases
Research and Development
Foreign Exchange Transactions
Stock-Based Compensation
Supplier Concentration
Customer Concentration
Licensed Right to Use Technology
Long-Lived Assets
Income Taxes
Net Loss Per Share
Variable Interest Entity
Recently Adopted Accounting Standards
Recently Issued Accounting Standards Not Yet Adopted
SCHEDULE OF FAIR VALUE ON A RECURRING BASIS
SUMMARY OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES
SCHEDULE OF ASSUMPTIONS USED IN VALUING WARRANTS
SCHEDULE OF KEY INPUTS DERIVATIVE
SCHEDULE OF CHANGES IN FAIR VALUE OF WARRANTS AND DERIVATIVES
SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE OF ASSETS
SCHEDULE OF FUTURE EXPECTED AMORTIZATION EXPENSE
SCHEDULE OF PROPERTY AND EQUIPMENT
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
SCHEDULE OF RESTRICTED STOCK AWARDS
SCHEDULE OF OPTION ACTIVITY FOR NEURONOS
SCHEDULE OF FAIR VALUE OF OPTION
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE
SUMMARY OF OUTSTANDING WARRANTS
SCHEDULE OF OTHER CURRENT ASSETS AND PREPAID EXPENSES
SUMMARY OF ACCRUED EXPENSES
SCHEDULE OF OPERATING LEASE LIABILITY
SCHEDULE OF LEASE RELATED COSTS
SCHEDULE OF LEASE OTHER INFORMATION
SCHEDULE OF MATURITY OF LEASE LIABILITIES
SCHEDULE OF POTENTIAL ANTI-DILUTIVE SECURITIES
SCHEDULE OF LONG-TERM DEBT
SCHEDULE OF LOAN PAYABLE
SCHEDULE OF PROFIT (LOSS) BEFORE TAXES
SCHEDULE OF DEFERRED TAX ASSET/LIABILITY
SCHEDULE OF DIFFERENCE EFFECTIVE INCOME TAX RATE
SCHEDULE OF STATUTORY US FEDERAL EFFECTIVE RATE
SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT
SCHEDULE OF MATURITY OF FUTURE LEASE PAYMENTS
OrganizationConsolidationAndPresentationOfFinancialStatementsTable [Table]
Ownership percentage
Reverse stock split
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Total assets measured and recorded at fair value
Total liabilities measured and recorded at fair value
Total short-term marketable securities, Fair value
Total short-term marketable securities, Unrealized gains and (losses)
Business Combination [Table]
Business Combination [Line Items]
Expected term warrants
Warrants and rights outstanding, measurement input
Maximum convertible shares
Risk-free rate
Balance at March 31, 2025
Change in fair value
Issuance
Extinguishment
Balance at March 31, 2026
Total cash, cash equivalents and restricted cash
Marketable securities:
Total marketable securities
Total cash, cash equivalents, marketable securities and restricted cash
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Estimated useful life of assets
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
2027
2028
2029
2030
2031
Total
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Net cash used in operating activities
Accumulated deficit
Cash equivalents and marketable securities
Cash deposit
Allowance for credit losses
Derivative liability description
Purchase of common stock, shares
Share price
Debt amount
Fair value of issued common stock
Fair value of the derivative liability
Restricted cash
Proceeds from issuance of secured promissory note
Cash FDIC insured amount
Concentration risk benchmark description
Number of repotable segments
Obsolescence reserves
Tax Rebate
Accumulated other comprehensive income
Concentration percentage
Other asset impairment charges
Non-controlling owners interest
Property and equipment, gross
Accumulated depreciation
Property and equipment, net
Depreciation and amortization
Unvested Number of Shares, Beginning balance
Weighted Average Grant Date Fair Value, Beginning balance
Number of Shares, Granted
Weighted Average Grant Date Fair Value, Granted
Number of Shares, Vested
Weighted Average Grant Date Fair Value, Vested
Number of Shares, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Unvested Number of Shares, Ending balance
Weighted Average Grant Date Fair Value, ending balance
Number of Options, Outstanding at beginning of period
Weighted Average Exercise Price - Options, Outstanding at beginning of period
Weighted Average Remaining Contractual Life - Options, Outstanding at end of period
Aggregate Intrinsic Value, Outstanding at beginning of period
Number of Options Outstanding, Granted
Weighted Average Exercise Price - Options, Granted
Number of Options Outstanding, Exercised
Weighted Average Exercise Price - Options, Exercised
Number of Options Outstanding, Forfeited
Weighted Average Exercise Price - Options, Forfeited
Number of Options, Outstanding at ending of period
Weighted Average Exercise Price - Options, Outstanding at ending of period
Aggregate Intrinsic Value, Outstanding at end of period
Number of Options Outstanding, Exercisable
Weighted Average Exercise Price - Options, Exercisable
Weighted Average Remaining Contractual Life - Options, Exercisable
Aggregate Intrinsic Value, Exercisable
Weighted average remaining contractual life - options, outstanding at beginning of period
Number of Options, Granted
Weighted Average Exercise Price of Options, Granted
Number of Options, Exercised
Weighted Average Exercise Price of Options, Exercised
Number of Options, Forfeited
Weighted Average Exercise Price of Options, Forfeited
Weighted Average Remaining Contractual Life of Options, Exercisable
Weighted average exercise price - options, forfeited
Weighted Average Remaining Contractual Life of Options, Outstanding
ScheduleOfFairValueOfOptionTable [Table]
Risk-free interest rate
Expected volatility
Dividend yield
Expected term (in years)
ScheduleOfStockBasedCompensationExpenseTable [Table]
Total stock-based compensation expense
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of Warrants
Exercise Price
Intrinsic Value
Date of Expiration
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Sale of Stock, Consideration Received Per Transaction
Sale of stock fee percentage
Public float value
Sale of net proceeds
Number of shares issued in transaction
Share purchase value
Stock issues during the period, shares
Fair value per share
Adjustments in additional paid in capital
Common stock minimum purchase amount
Beneficial ownership limitation percentage
Purchase warrants
Warrants price
Proceeds from private placement
Warrant exercise price
Commission paid
Other fees
Stock option shares authorized for issuance
Number of shares available for grant
Vesting period
Share based compensation
Weighted average remaining service period
Expiration period
Unrecognized share based compensation
Weighted average fair value of options
Share compensation expense
Option repricing
Exercise price in excess
Incremental stock compensation expense
Option exercise price
Stock based compensation
Number of additionl shares reserve for issuance
Unrecognized stock-based compensation expense
Warrants to purchase
Warrants Exercise
Other fees
Weighted average remaining service period
Stock issued during the period, shares
Number of shares issued
Research and development
Prepaid insurance
Prepaid rents and tenant improvement
Value added tax receivable
Deposits to secure manufacturing materials
Demonstration materials
Other
Total other current assets and prepaid expenses
Research and development
Professional fees
Employee salaries and benefits
Accrued severance
Accrued interest
Deferred revenue
Goods received not invoiced
Other
Total accrued expenses and other current liabilities
PayablesAndAccrualsTable [Table]
Cash
Taxes Payable, Current
Schedule Of Operating Lease Liability
Right-of-use assets
Operating lease liability short-term
Operating lease liability long-term
Total lease liabilities
Weighted Average Remaining Lease Term
Weighted-average discount rate - operating leases
Schedule Of Lease Related Costs
Operating lease cost
Short-term lease costs
Sublease income
Total lease cost
Operating cash flows for operating leases
2027
2028
2029
2030
2031
Thereafter
Total lease payments
Less: amount of lease payments representing interest
Present value of future lease payments
Operation lease description
Operating lease liability
Operating lease liability in exchange
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities
Warrants included in calculation of diluted net loss per share
Short-Term Debt [Table]
Short-Term Debt [Line Items]
Principal balance outstanding
Paid in kind interest
Debt discount
Amortization of debt discount
Total
Schedule of Long-Term Debt Instruments [Table]
Principal amount
Interest rate
Percentage of interest payable in cash
Percentage of interest payable in kind
Royalty interest percentage
Price per share
Warrants exercise price
Advanced financing from related party
Warrants term
Warrants to purchase common stock
Debt instrument term
Interest rate description
Debt instrument, interest rate
Principal in restricted account
Debt instrument, principal repayable
Shares issued of common stock
Debt amount
Shares available for resale
Unrestricted cash
Monitoring fees
Amount outstanding
Monthly payments
Amount outstanding
Due date
Domestic
Foreign
Net operating loss carryforwards
Research and development tax credits
Research and development tax credit capitalization
Other
Depreciation
Stock-based compensation
Reserves and accruals
Right-of-use asset
Lease liability
Net deferred tax
Valuation allowance
Net deferred tax asset
ScheduleOfDifferenceEffectiveIncomeTaxRateTable [Table]
U.S. federal statutory tax rate
U.S. federal statutory tax rate
Current state and local income taxes, net of federal benefit
Current state and local income taxes, net of federal benefit
Change in valuation allowance
Change in valuation allowance
Other
Other
Other foreign jurisdictions
Other foreign jurisdictions
Research and development tax credits
Other foreign jurisdictions
Changes in valuation allowance
Changes in valuation allowance
Subpart F Income
Subpart F Income
Share-based payment awards
Share-based payment awards
Other
Other
Other adjustments
Other adjustments
Provision for income taxes
Other adjustments
Federal income tax at statutory rate
State income tax, net of federal benefit
Permanent items
Non-deductible compensation
Research and development tax credits
Foreign tax rate differential
Change to foreign NOL’s
Effective Income Tax Rate Reconciliation [Table]
Effective Income Tax Rate Reconciliation [Line Items]
Operating loss carryforwards
Taxable income
Operating loss carryforward expire description
Deferred tax liabilities, deferred expense, capitalized research and development costs
Tax credit carryforward, amount
Tax credit carryforward, description
Federal tax percentage
Unrecognized tax benefits
Income tax limitation description
Federal income tax rate
Product Liability Contingency [Table]
Payments for development and milestone payment
Remaining future milestone payments
Sales related milestones payments
Future payments based on certain milestones
Warrants to purchase common stock
Warrants to purchase common stock, value
Outstanding amount under purchase
Cash deposits
Segment Reporting [Table]
Sle of stock per share
Shares issued price per share
Proceeds from issuance of common stock
Amount of terminated loan
Proceeds from related party debt
Equity ownership percentage
Related party invested
Segment Reporting [Line Items]
Capital expenditures
Cost of revenues
Research and development
Selling, general, and administrative
Loss from operations
Other non-operating income/(expense)
Net loss before income taxes
Cash used in operations
Cash provided by investing
Cash provided by financing
Impact of exchange rates
Net change for the year
Cash, cash equivalents and marketable securities
All other assets
Total liabilities
Net assets
Lessee, Lease, Description [Table]
Contract term
Lease revenue
Useful Life
Depreciation expense
No Insider Trading Flag.
Warrant liability.
Pre-funded Warrants [Member]
Loan Agreement [Member]
Promissory Note [Member]
Paid in kind interest amount.
Amortization of Debt Discount.
Loan and Security Agreement [Member]
Debt instrument interest rate payable in cash percentage.
Sale of stock fee percentage.
2025 ATM [Member]
Royalty interest percentage.
Debt instrument interest rate payable in kind percentage.
Public float value.
Amended Loan Agreement [Member]
Note Purchase Agreement [Member]
Debt instrument of restricted account.
Streeterville Capital LLC [Member]
Unrestricted cash.
Number of payments.
Loan payable due date description.
Purchase Agreement [Member]
Beneficial ownership limitation percentage.
Offset taxable income rate.
No Expiration [Member]
Operating loss carryforward expire term.
2013 Beyond Air Equity Incentive Plan [Member]
Effective income tax rate reconciliation at federal statutory income tax rate percentage.
Research and development tax credit capitalization.
Deferred tax assets tax deferred expense compensation and depreciation.
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from Capital loss carryforward.
Deferred tax assets reserves and accruels.
Deferred tax assets right of use asset.
Deferred tax assets lease liability.
2013 BA Plan [Member]
Effective income tax rate reconciliation change to foreign net operating loss.
Sale of common stock and prefunded warrants.
Issuance of common stock at market equity offering shares.
Milestone payments.
Option Agreement [Member]
Sales related milestones payments.
Payments for development and milestone payment.
NitricGen, Inc [Member
NitricGen Agreement [Member]
Payment for milestone method revenue recognized.
After Six Months [Member]
Next Milestones [Member]
Supplier [Member]
Proceeds from long term debt.
Debt discount.
Derivatives liability.
Debt principal balance converted to equity.
Right of use assets acquired under operating leases.
NeuroNos Ltd [Member]
Short term finance liability.
Beyond Cancer Ltd [Member]
Certain Investors [Member]
Proceeds from sale of common stock of neuronos.
Amount of terminated loan.
Investors [Member]
Payments to security deposits made on operating leases.
Subscription Agreement [Member]
Gain loss on termination of right of use asset.
Beyond Air [Member]
Business Segment [Member]
Variable Interest Entities [Member]
Capital expenditures cost.
2013 BA EquityIncentivePlan [Member]
2021 Beyond Cancer Ltd Equity Incentive Plan [Member]
Going Concern Liquidity and Other Uncertainties [Policy Text Block]
Cash and cash equivalents and marketable securities.
2023 Neuro Nos Ltd Equity Incentive Plan [Member]
Other Risks and Uncertainties [Policy Text Block]
Operating Leases [Text Block]
Operating lease income.
Lung Fit PH [Member]
LungFit® PH [Member]
Beyond Air Inc. [Member]
Fair Value Measurement Inputs and Valuation Techniques of Derivative [Table Text Block]
Recently Issued Accounting Standards Not Yet Adopted [Policy Text Block]
Avenue Agreement [Member]
March 2024 Raise [Member]
Avenue Extension Agreement [Member]
September 2024 equity offering [Member]
September 2024 Debt Instrument [Member]
September 2025 Inducement [Member]
Sub Total [Member]
Customerr Concentration [Policy Text Block]
January, 2026 Equity Offering [Member]
Customers One [Member]
Customers Two [Member]
Pre Funded Warrants Sep 2024 [Member]
Pre Funded Warrants jan 2026 [Member]
Supplier Concentration [Policy Text Block]
First Third Party Vendors [Member]
Second Third Party Vendors [Member]
Third Party Vendors [Member]
Warrants Intrinsic Value.
Tax rebate.
Warrants expiration date description.
Schedule of Property and Equipment UsefulLife of Assets [Table Text Block]
Clinical and Medical Equipment [Member]
Equipment Deployable as Part of Service Offering [Member]
2021 Employee Stock Purchase Plan [Member]
Accrued prepaid research and development expenses.
Goods received not invoiced.
Interest severance current.
Warrant Liability [Policy Text Block]
Schedule Of Change In Fair Value Of Warrants And Derivatives [Table Text Block]
Schedule Of Operating Lease Liability [Table Text Block]
Other Lease [Table Text Block]
Prepaid research and development.
Number of reportable segments disclosed by definition flag.
Extinguishment.
2026 Pre-funded Warrants [Member]
2026 Common Warrants [Member]
Cypriot Tax [Member]
2025 Option Repricing [Member]
Federal income tax at statutory rate.
Mutual Funds [Member]
Steve Lisi [Member]
Reduction in the value of shares issued during the period as a result of a reverse stock split.
Schedule Of Difference Effective Income Tax Rate Reconciliation [Table Text Block]
Effective Income tax rate reconciliation difference state and local income taxes.
Income tax reconciliation difference state and local income taxes.
Income tax reconciliation difference tax credits research.
Effective income tax rate reconciliation difference tax credits research.
Income tax reconciliation tax subpart f income.
Effective income tax rate reconciliation subpart f income.
Effective income tax rate reconciliation difference share based compensation excess tax benefit amount.
Income tax reconciliation difference other adjustments.
Income tax reconciliation difference other reconciling items.
Effective income tax rate reconciliation difference share based compensation excess tax benefit percent.
Effective income tax rate reconciliation difference other adjustments.
Effective income tax rate reconciliation difference other reconciling items percent.
Useful Life, Lease Term [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Treasury Stock, Value
Equity, Attributable to Parent
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Gross Profit
Operating Expenses
Interest Expense, Nonoperating
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Income Tax Expense (Benefit)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Gain (Loss), Foreign Currency Transaction, after Tax
GainLossOnTerminationOfRightOfUseAsset
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Increase (Decrease) in Inventories
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Accounts Payable
Payments to Acquire Marketable Securities
PaymentsToSecurityDepositsMadeOnOperatingLeases
Payments to Acquire Property, Plant, and Equipment
Payments of Debt Issuance Costs
Repayments of Bank Debt
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Lessee, Leases [Policy Text Block]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Restricted Cash and Cash Equivalent
Intangible Asset, Finite-Lived, after Accumulated Amortization
Restricted Cash
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Payments for Other Fees
PrepaidResearchAndDevelopment
AccruedResearchAndDevelopmentExpenses
Other Accrued Liabilities, Current
Sublease Income
Lease, Cost
Lessee, Operating Lease, Liability, to be Paid, Year One
Lessee, Operating Lease, Liability, to be Paid, Year Two
Lessee, Operating Lease, Liability, to be Paid, Year Three
Lessee, Operating Lease, Liability, to be Paid, Year Four
Lessee, Operating Lease, Liability, to be Paid, Year Five
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PaidInKindInterestAmount
Debt Instrument, Unamortized Discount
Long-Term Debt, Gross
Debt Conversion, Original Debt, Amount
NumberOfPayments
Deferred Tax Assets, Other
DeferredTaxAssetsTaxDeferredExpenseCompensationAndDepreciation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deferred Tax Assets, Gross
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
EffectiveIncomeTaxRateReconciliationDifferenceStateAndLocalIncomeTaxes
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent
IncomeTaxReconciliationDifferenceTaxCreditsResearch
EffectiveIncomeTaxRateReconciliationDifferenceTaxCreditsResearch
Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent
EffectiveIncomeTaxRateReconciliationSubpartFIncome
EffectiveIncomeTaxRateReconciliationDifferenceShareBasedCompensationExcessTaxBenefitPercent
IncomeTaxReconciliationDifferenceOtherAdjustments
EffectiveIncomeTaxRateReconciliationDifferenceOtherAdjustments
EffectiveIncomeTaxRateReconciliationDifferenceOtherReconcilingItemsPercent
Effective Income Tax Rate Reconciliation, Percent
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right